 |
|
|
| |
Long-term Safety and Efficacy of CAB and
RPV as 2-Drug Oral Maintenance Therapy
|
| |
| |
Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
David A Margolis,1Cynthia Brinson,2Graham H Smith,3Joseph J Eron,4Gary J Richmond,5Roger P LeBlanc,6Peter E Williams,7William R Spreen,1Kenneth C Sutton,1Britt S Stancil8
1ViiV Healthcare, Research Triangle Park, NC, USA; 2Central Texas Clinical Research, Austin, TX, USA; 3Maple Leaf Medical Clinic, Toronto, Ontario, Canada; 4University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 5Gary J Richmond MD PA, Ft Lauderdale, FL, USA; 6Clinique OPUS, Montreal, Quebec, Canada; 7Janssen Research and Development, Beerse, Belgium; 8PAREXEL International, Durham, NC, USA
CROI/2015: Cabotegravir and Rilpivirine As 2-Drug Oral Maintenance Therapy: LATTE W96 Results....
http://www.natap.org/2015/CROI/croi_77.htm
|
| |
|
|
|
|
|
